<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">CJC Open</journal-id><journal-id journal-id-type="iso-abbrev">CJC Open</journal-id><journal-id journal-id-type="pmc-domain-id">3811</journal-id><journal-id journal-id-type="pmc-domain">cjco</journal-id><journal-title-group><journal-title>CJC Open</journal-title></journal-title-group><issn pub-type="epub">2589-790X</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10140739</article-id><article-id pub-id-type="pmcid-ver">PMC10140739.1</article-id><article-id pub-id-type="pmcaid">10140739</article-id><article-id pub-id-type="pmcaiid">10140739</article-id><article-id pub-id-type="pmid">37124964</article-id><article-id pub-id-type="doi">10.1016/j.cjco.2023.01.005</article-id><article-id pub-id-type="pii">S2589-790X(23)00006-9</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Prevalence, Perceptions, and Patterns of Cannabis Use Among Cardiac Inpatients at a Tertiary-Care Hospital: A Cross-Sectional Survey</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name name-style="western"><surname>Walker</surname><given-names initials="KL">Kathryn L.</given-names></name><degrees>MScPT</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au2"><name name-style="western"><surname>Mackler</surname><given-names initials="SA">Sarah A.</given-names></name><degrees>BPh, MBA</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au3"><name name-style="western"><surname>Noble</surname><given-names initials="SM">Shireen M.</given-names></name><degrees>MSPH</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au4"><name name-style="western"><surname>Gaudreault</surname><given-names initials="AE">Adrienne E.</given-names></name><degrees>BSc, MPH</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au5"><name name-style="western"><surname>Mitchell</surname><given-names initials="S">Scott</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au6"><name name-style="western"><surname>Reid</surname><given-names initials="RD">Robert D.</given-names></name><degrees>PhD, MBA</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au7"><name name-style="western"><surname>Pipe</surname><given-names initials="AL">Andrew L.</given-names></name><degrees>CM MD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au8"><name name-style="western"><surname>Coutinho</surname><given-names initials="T">Thais</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au9"><name name-style="western"><surname>Mir</surname><given-names initials="H">Hassan</given-names></name><degrees>MD, FRCPC</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au10"><name name-style="western"><surname>Mullen</surname><given-names initials="KA">Kerri-Anne</given-names></name><degrees>PhD</degrees><email>kmullen@ottawaheart.ca</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#8727;</xref></contrib><aff id="aff1"><label>a</label>Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada</aff><aff id="aff2"><label>b</label>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada</aff></contrib-group><author-notes><corresp id="cor1"><label>&#8727;</label>Corresponding author: Kerri-Anne Mullen, 40 Ruskin Street, H-S134, Ottawa, Ontario K1Y 4W7, Canada. Tel.: +1-613-696-7000, x19095. <email>kmullen@ottawaheart.ca</email></corresp></author-notes><pub-date pub-type="collection"><month>4</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>28</day><month>1</month><year>2023</year></pub-date><volume>5</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">434534</issue-id><fpage>315</fpage><lpage>324</lpage><history><date date-type="received"><day>4</day><month>11</month><year>2022</year></date><date date-type="accepted"><day>17</day><month>1</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>28</day><month>01</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>29</day><month>04</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-05-01 11:26:21.507"><day>01</day><month>05</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 The Authors</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="abs0010"><sec><title>Background</title><p>Cannabis use may adversely affect cardiovascular health. Patterns of use by cardiac patients are unknown. We evaluated the prevalence, perceptions, and patterns of cannabis use among cardiac inpatients.</p></sec><sec><title>Methods</title><p>A consecutive cross-section of cardiac inpatients, hospitalized between November 2019 and May 2020, were surveyed in-person or via telephone. Descriptive statistics and logistic regression were used to examine the characteristics of cannabis use.</p></sec><sec><title>Results</title><p>The prevalence of past-12-month cannabis use was 13.8% (95% confidence interval [CI]: 11.8%-16.0%). Characteristics independently associated with cannabis use were as follows: age &lt; 64 years (&lt; 44 years, odds ratio [OR]&#160;= 3.96 [95% CI: 1.65-9.53]; age 45-64 years, OR&#160;= 2.72 [95% CI: 1.65-4.47]); tobacco use in the previous 6 months (OR&#160;= 1.91 [95% CI: 1.18-3.07]); having a cannabis smoker in one&#8217;s primary social group (OR&#160;= 4.17 [95% CI: 2.73-6.38]); and a history of a mental health diagnosis (OR&#160;= 1.82 [95% CI: 1.19-2.79]). Among those using cannabis, 70.5% reported smoking or vaping it; 47.2% reported daily use. Most did not know the tetrahydrocannabinol (THC; 71.6%) or cannabidiol (CBD; 83.3%) content of their cannabis, or the dose of cannabis in their edibles (66.7%). As defined by Canada&#8217;s Lower Risk Cannabis Use Guidelines, 96.7% of cannabis users reported &#8805; 1 higher-risk use behaviour (mean&#160;= 2.3, standard deviation&#160;= 1.2). Over 60% of patients expressed no intention to quit or reduce cannabis use in the next 6 months.</p></sec><sec><title>Conclusions</title><p>Cannabis use appears prevalent among cardiac patients. Most users demonstrated higher-risk use behaviours and low intentions to quit. Further work is needed to understand the impacts of cannabis use on the cardiovascular system and to develop guidelines and educational tools relating to lower-risk use, for cardiac patients and providers.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#201;sum&#201;</title><sec><title>Contexte</title><p>L&#8217;utilisation du cannabis peut nuire &#224; la sant&#233; cardiovasculaire, mais les habitudes d&#8217;utilisation des patients atteints de troubles cardiaques ne sont pas connues. Nous avons &#233;valu&#233; la pr&#233;valence, les perceptions et les habitudes d&#8217;utilisation du cannabis chez des patients hospitalis&#233;s pr&#233;sentant des troubles cardiaques.</p></sec><sec><title>M&#233;thodologie</title><p>Une analyse transversale a &#233;t&#233; r&#233;alis&#233;e en interrogeant en personne ou au t&#233;l&#233;phone des patients hospitalis&#233;s cons&#233;cutivement entre novembre 2019 et mai 2020 et pr&#233;sentant des troubles cardiaques. Des statistiques descriptives et une r&#233;gression logistique ont &#233;t&#233; utilis&#233;es pour examiner les caract&#233;ristiques li&#233;es &#224; l&#8217;utilisation du cannabis.</p></sec><sec><title>R&#233;sultats</title><p>La pr&#233;valence de l&#8217;utilisation du cannabis au cours des 12 mois pr&#233;c&#233;dents &#233;tait de 13,8 % (intervalle de confiance [IC] &#224; 95 % : 11,8 % &#224; 16,0 %). Les caract&#233;ristiques ind&#233;pendamment associ&#233;es &#224; l&#8217;utilisation du cannabis &#233;taient les suivantes : &#226;ge &lt; 64 ans (&lt; 44 ans, rapport de cotes [RC]&#160;= 3,96 [IC &#224; 95 % : 1,65 &#224; 9,53]; &#226;ge de 45 &#224; 64 ans, RC&#160;= 2,72 [IC &#224; 95 % : 1,65 &#224; 4,47]); tabagisme dans les six mois pr&#233;c&#233;dents (RC&#160;= 1,91 [IC &#224; 95 % : 1,18 &#224; 3,07]); pr&#233;sence d&#8217;un consommateur de cannabis au sein du cercle social principal (RC&#160;= 4,17 [IC &#224; 95 % : 2,73 &#224; 6,38]); et diagnostic ant&#233;rieur li&#233; &#224; la sant&#233; mentale (RC&#160;= 1,82 [IC &#224; 95 % : 1,19 &#224; 2,79]). Parmi les utilisateurs de cannabis, 70,5 % d&#8217;entre eux ont rapport&#233; qu&#8217;ils fumaient ou vapotaient et 47,2 % ont d&#233;clar&#233; en consommer quotidiennement. La plupart ne connaissaient pas le contenu en t&#233;trahydrocannabinol (THC; 71,6 %) ou en cannabidiol (CBD; 83,3 %) du cannabis consomm&#233;, ou la dose contenue dans les aliments &#224; base de cannabis consomm&#233;s (66,7 %). Au total, 96,7 % des utilisateurs de cannabis ont rapport&#233; &#8805; 1 comportement(s) &#224; risque &#233;lev&#233; (moyenne&#160;= 2,3, &#233;cart-type&#160;= 1,2) selon les Recommandations canadiennes pour l&#8217;usage du cannabis &#224; moindre risque. Par ailleurs, plus de 60 % des patients n&#8217;ont exprim&#233; aucune intention d&#8217;interrompre ou de diminuer leur consommation de cannabis au cours des six prochains mois.</p></sec><sec><title>Conclusions</title><p>L&#8217;utilisation du cannabis semble courante chez les patients qui pr&#233;sentent des troubles cardiaques. La plupart des utilisateurs ont d&#233;montr&#233; des comportements &#224; risque &#233;lev&#233;, et une faible intention de mettre fin &#224; leur consommation. D&#8217;autres &#233;tudes sont requises pour caract&#233;riser les r&#233;percussions de l&#8217;utilisation du cannabis sur l&#8217;appareil cardiovasculaire et &#233;laborer des lignes directrices et des outils &#233;ducatifs &#224; l&#8217;intention des patients atteints de troubles cardiaques et des professionnels de la sant&#233; en vue de favoriser un usage &#224; moindre risque.</p></sec></trans-abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="p0010">Evidence suggests that cannabis use is associated with cardiovascular harm. A recent systematic review found that nonmedical cannabis use was associated with an increased likelihood of myocardial infarction and stroke.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> Other investigators have identified an associated increased risk of an acute coronary syndrome,<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref><sup>,</sup><xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> dysrhythmias,<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> and chronic cardiovascular disease.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Smoking cannabis may be associated with many of the same cardiovascular risks as smoking tobacco, given its effects on blood pressure, inflammation, and cardiac rhythm.<xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref> Cannabis may also interact adversely with certain cardiovascular drugs.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref></p><p id="p0015">Cardiovascular risks notwithstanding, studies have supported the therapeutic benefits of cannabis in managing certain disorders and symptoms, including the following: neuropathic pain and posttraumatic stress disorder; improved appetite in patients with cancer or human immunodeficiency virus (HIV); decreased spasticity from multiple sclerosis; and reduced frequency of certain forms of epileptic seizures.<xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib13" ref-type="bibr">13</xref></p><p id="p0020">Recreational cannabis was legalized in Canada between October 2018 and October 2019.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> Canada has published its Lower Risk Cannabis Use Guidelines (LRCUGs) designed to provide the public and clinicians with evidence-based recommendations to reduce the risks associated with cannabis use.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> These guidelines provide little information for individuals with cardiovascular disease (CVD). Current knowledge is limited regarding the prevalence and patterns of cannabis use among adults with medical conditions,<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> particularly those with CVD.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> Given the potential risks that cannabis use may pose to cardiovascular patients, understanding the nature and dimension of its use within this population is important.</p><p id="p0025">The purpose of this evaluation was to examine the prevalence, perceptions, and patterns of cannabis use among a consecutive series of inpatients at a tertiary-care cardiac hospital in Ontario, Canada, to gather insights that could lead to the improvement of patient care.</p><sec id="sec1"><title>Methods</title><sec id="sec1.1"><title>Design and setting</title><p id="p0030">We conducted a cross-sectional survey of a consecutive series of patients admitted to inpatient cardiology and cardiac surgery units at the University of Ottawa Heart Institute between November 2019 and May&#160;2020.</p></sec><sec id="sec1.2"><title>Participants</title><p id="p0035">Patients were eligible for the survey if they met the following criteria: (i) they were admitted to 1 of 3 cardiac inpatient units at the institute between November 11, 2019, and May 14, 2020; (ii) they could speak and comprehend English or French; (iii) they were not severely cognitively or hearing impaired; and (iv) they were healthy enough to participate in the survey. The survey was administered to participants in-person during their hospitalization, or by telephone posthospitalization. Participants provided consent to participate in the survey.</p></sec><sec id="sec1.3"><title>Data sources</title><p id="p0040">Four of the authors (K.W., K.M., S.N., S.M.) developed a survey using questions adapted from the following existing, validated surveys: National Cannabis Survey 2018 &amp; 2019<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref>; Canadian Cannabis Survey (CCS) 2018<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> &amp; 2019<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref>; Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU)<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref>; and the Canadian Alcohol Tobacco and Drugs Survey 2017.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> The survey was piloted and revised prior to the start of the evaluation. The primary variable of interest was self-reported cannabis use in the past year. A 12-month recall period was selected, as this permits measurement of current or recent cannabis use and enables comparisons with other national surveys (CCS and Canadian Alcohol Tobacco and Drugs Survey). Previous year cannabis use was measured by asking patients &#8220;Have you ever used cannabis?,&#8221; with the following response options read to them: &#8220;No, I have never used cannabis; Yes, I have only tried cannabis once in my life but not in the past year; Yes, I have used it more than once but not within the past year; Yes, I have used it within the past year.&#8221; Those who reported cannabis use in the previous year were asked the following further questions about their use: patterns of use; history of use; methods of administration; source of the cannabis; knowledge of tetrahydrocannabinol (THC) and cannabidiol (CBD) content; reasons for use; and co-use with other substances. All participants were asked about the following: their perceptions and feelings toward cannabis use; their use of tobacco, e-cigarettes, and alcohol; reason for their hospital admission; their history of mental health diagnosis; their other substance use; and their sociodemographic characteristics (age,&#160;sex, ethnic background, employment status, level of education). Participants had the option to have the survey administered in English or French. A copy of the survey&#160;questions used in this analysis is available in the <xref rid="appsec1" ref-type="sec">Supplemental Methods S1</xref>.</p></sec><sec id="sec1.4"><title>Reduction of bias</title><p id="p0045">To reduce potential biases, we attempted to survey a consecutive series of patients by approaching patients in chronological order based on admission date and time. Evaluation staff received training in survey administration and followed a standard operating procedure to ensure consistency in the delivery of the survey.</p></sec><sec id="sec1.5"><title>Sample size</title><p id="p0050">The primary objective was to measure prevalence of cannabis use, and we aimed to survey at least 150 participants who had used cannabis over the past year. A target sample size of 1012 was calculated based on an expected prevalence of cannabis use in the past 12 months of 15%,<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> an alpha of 0.05, and an absolute error (measure of precision) of &#177; 2.2%.</p></sec><sec id="sec1.6"><title>Statistical analysis</title><p id="p0055">Descriptive statistics were used to summarize cannabis prevalence, perceptions, and sociodemographic characteristics. Response categories with cell sizes less than 10 were merged with other categories to protect respondent identity.</p><p id="p0060">Three quantitative variables (number of standard drinks per week, length of hospital stay in days, and age) were converted to categorical variables for data analysis. The Canadian guidelines for low-risk alcohol consumption<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> were used to group &#8220;number of standard drinks per week&#8221; into the following binary variable: &#8220;Consumes more than guidelines of alcohol per week (higher risk) or consumes within guidelines per week (lower risk).&#8221;</p><p id="p0065">Cannabis use characteristics of this cardiac inpatient sample were compared post hoc to the LRCUGs<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> to examine how many patients were reporting higher-risk cannabis use. Five of the LRCUGs&#8217; 10 higher-risk behaviours were assessed in our survey (initiating cannabis use before age 25 years, driving within 2 hours of consuming cannabis, smoking cannabis, frequency of cannabis use &gt; once per week, co-use of cannabis and tobacco in the previous 6 months). The responses were converted into binary (yes/no) variables; the &#8220;yes&#8221; responses were summed for each patient who used cannabis, to determine the number of higher-risk behaviours per patient.</p><p id="p0070">Logistic regression was used to examine the associations between cannabis use and sociodemographic characteristics. Unadjusted odds ratios (ORs) were calculated for each independent variable, with cannabis use in the past 12 months as the dependent variable. The independent variables examined were sex, age group, education, employment status, tobacco use, alcohol use, opioid use, exposure to cannabis smoke in the home, cannabis use in primary social group, and history of a mental health diagnosis. These variables were selected based on clinical experience and prior literature suggesting that they have a potential association with cannabis use. Following the univariate analyses, 2 multivariable models were built. The first model included all variables. The second model included all variables with a significant univariate association with cannabis use, in addition to age and biological sex. The following tests were used to compare the 2 multivariable models and select the model with the best fit: Nagelkerke R value (a larger number suggests better model fit); &#8211;2 log likelihood (smaller number suggests better fit); and Block 1 (reduced model) vs Block 2 (full model) comparison and examination of the likelihood ratio &#967;<sup>2</sup> test for the additional terms added in the second block. All assumptions of logistic regression were tested and found to have been met. SPSS Statistics for Windows (version 28.0; IBM, Armonk, NY) was used to conduct all statistical analyses.</p><p id="p0075">The full dataset was used to calculate descriptive statistics. In preparation for logistic-regression analysis, missing data were addressed as follows: Any cases missing more than 33% of responses for the variables included in the logistic regression were removed from the dataset (n&#160;= 12). The pattern of &#8220;missingness&#8221; of the data in the trimmed dataset was then examined using SPSS Statistics missing-data analysis. Multiple imputations (5 iterations), using SPSS Statistics (automatic imputation) were performed to impute the missing data. A pooled estimate of the 5 dataset iterations was used to conduct the logistic-regression analysis.</p></sec><sec id="sec1.7"><title>Ethics approval</title><p id="p0080">This project was reviewed by the Ottawa Health Science Network Research Ethics Board and approved as a quality-improvement evaluation.</p></sec></sec><sec id="sec2"><title>Results</title><p id="p0085">A total of 1616 cardiac patients were admitted and discharged from participating inpatient units during the evaluation period. Prior to the COVID-19 pandemic lockdown in March 2020, patients were approached consecutively while&#160;they were in the hospital. If patients were not reached while they were in the hospital or during the pandemic lockdown, they were contacted by phone in order of discharge, to ask them to complete the survey. Of those approached, 124 patients (7.7%) were not eligible for the survey, and 403 patients (24.9%) declined or were unreachable. Of the eligible patients, 1089 (73.0%) completed the survey (<xref rid="fig1" ref-type="fig">Fig.&#160;1</xref>).<fig id="fig1" position="float" orientation="portrait"><label>Figure&#160;1</label><caption><p>Selection of participants for survey.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p><sec id="sec2.1"><title>Prevalence</title><p id="p0090">The overall prevalence of cannabis use in the past year for our sample was 13.8% (95% confidence interval [CI], 11.8%-16.0%; n&#160;= 150; <xref rid="tbl1" ref-type="table">Table&#160;1</xref>), and the prevalence of ever using cannabis in one&#8217;s life was 42.1% (95% CI, 39.2%-45.1%). Cardiac inpatients who reported cannabis use in the previous year were, on average, 9 years younger than those who had not used cannabis in the previous year (mean age 58.3 &#177; 13.1 vs 67.5 &#177; 11.9 years; <italic toggle="yes">P</italic> &lt; 0.001).<table-wrap position="float" id="tbl1" orientation="portrait"><label>Table&#160;1</label><caption><p>Prevalence of cannabis use in cardiac inpatients, by sociodemographic, health, and social/environmental characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="3">Variable</th><th colspan="2" rowspan="1">Cannabis use, in past 12 months<hr/></th><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1"/></tr><tr><th colspan="1" rowspan="1">No<hr/></th><th colspan="1" rowspan="1">Yes<hr/></th><th colspan="1" rowspan="1">Total<hr/></th><th colspan="1" rowspan="1">Prevalence of cannabis use, in past 12 months<hr/></th></tr><tr><th colspan="1" rowspan="1">n (%)</th><th colspan="1" rowspan="1">n (%)</th><th colspan="1" rowspan="1">n</th><th colspan="1" rowspan="1">% (95% CI)</th></tr></thead><tbody><tr><td colspan="2" rowspan="1">Total</td><td colspan="1" rowspan="1">939</td><td colspan="1" rowspan="1">150</td><td align="center" colspan="1" rowspan="1">1089</td><td colspan="1" rowspan="1">13.8 (11.8&#8211;16.0)</td></tr><tr><td colspan="6" rowspan="1">Sociodemographic</td></tr><tr><td rowspan="3" colspan="1">Sex</td><td colspan="1" rowspan="1">Male</td><td colspan="1" rowspan="1">647 (68.9)</td><td colspan="1" rowspan="1">110 (73.3)</td><td align="center" colspan="1" rowspan="1">757</td><td colspan="1" rowspan="1">14.5 (12.2&#8211;17.2)</td></tr><tr><td colspan="1" rowspan="1">Female</td><td colspan="1" rowspan="1">292 (31.1)</td><td colspan="1" rowspan="1">40 (26.7)</td><td align="center" colspan="1" rowspan="1">332</td><td colspan="1" rowspan="1">12.0 (8.9&#8211;15.9)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="4" colspan="1">Age group, y</td><td colspan="1" rowspan="1">&#8804; 44</td><td colspan="1" rowspan="1">31 (3.3)</td><td colspan="1" rowspan="1">18 (12.0)<xref rid="tbl1fnlowast" ref-type="table-fn">&#8727;</xref></td><td align="center" colspan="1" rowspan="1">49</td><td colspan="1" rowspan="1">36.7 (24.3&#8211;50.7)</td></tr><tr><td colspan="1" rowspan="1">45&#8211;64</td><td colspan="1" rowspan="1">338 (36.0)</td><td colspan="1" rowspan="1">86 (57.3)<xref rid="tbl1fnlowast" ref-type="table-fn">&#8727;</xref></td><td align="center" colspan="1" rowspan="1">424</td><td colspan="1" rowspan="1">20.3 (16.7&#8211;24.3)</td></tr><tr><td colspan="1" rowspan="1">&#8805; 65</td><td colspan="1" rowspan="1">570 (60.7)</td><td colspan="1" rowspan="1">46 (30.7)</td><td align="center" colspan="1" rowspan="1">616</td><td colspan="1" rowspan="1">7.5 (5.6&#8211;9.7)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="3" colspan="1">Some postsecondary education</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">366 (39.6)</td><td colspan="1" rowspan="1">56 (38.1)</td><td align="center" colspan="1" rowspan="1">422</td><td colspan="1" rowspan="1">13.3 (10.3&#8211;16.8)</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">559 (60.4)</td><td colspan="1" rowspan="1">91 (61.9)</td><td align="center" colspan="1" rowspan="1">650</td><td colspan="1" rowspan="1">14.0 (11.5&#8211;16.8)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="3" colspan="1">Ethnicity</td><td colspan="1" rowspan="1">European/non-Indigenous North American</td><td colspan="1" rowspan="1">815 (88.6)</td><td colspan="1" rowspan="1">135 (91.2)</td><td align="center" colspan="1" rowspan="1">950</td><td colspan="1" rowspan="1">14.2 (12.1&#8211;16.5)</td></tr><tr><td colspan="1" rowspan="1">Other</td><td colspan="1" rowspan="1">105 (11.4)</td><td colspan="1" rowspan="1">13 (8.8)</td><td align="center" colspan="1" rowspan="1">118</td><td colspan="1" rowspan="1">11.0 (6.3&#8211;17.6)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">2</td><td align="center" colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="4" colspan="1">Employment status</td><td colspan="1" rowspan="1">Employed</td><td colspan="1" rowspan="1">275 (29.8)</td><td colspan="1" rowspan="1">51 (34.7)</td><td align="center" colspan="1" rowspan="1">326</td><td colspan="1" rowspan="1">15.6 (12.0&#8211;19.9)</td></tr><tr><td colspan="1" rowspan="1">Retired</td><td colspan="1" rowspan="1">552 (59.9)</td><td colspan="1" rowspan="1">65 (44.2)<xref rid="tbl1fnlowast" ref-type="table-fn">&#8727;</xref></td><td align="center" colspan="1" rowspan="1">617</td><td colspan="1" rowspan="1">10.5 (8.3&#8211;13.1)</td></tr><tr><td colspan="1" rowspan="1">Unemployed/receiving disability income support</td><td colspan="1" rowspan="1">95 (10.3)</td><td colspan="1" rowspan="1">31 (21.1)<xref rid="tbl1fnlowast" ref-type="table-fn">&#8727;</xref></td><td align="center" colspan="1" rowspan="1">126</td><td colspan="1" rowspan="1">24.6 (17.7&#8211;32.6)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="6" rowspan="1">Health services utilization</td></tr><tr><td rowspan="5" colspan="1">Admission diagnosis</td><td colspan="1" rowspan="1">Coronary artery disease</td><td colspan="1" rowspan="1">576 (61.3)</td><td colspan="1" rowspan="1">89 (59.3)</td><td align="center" colspan="1" rowspan="1">665</td><td colspan="1" rowspan="1">13.4 (11.0&#8211;16.1)</td></tr><tr><td colspan="1" rowspan="1">Valvular disease</td><td colspan="1" rowspan="1">141 (15.0)</td><td colspan="1" rowspan="1">28 (18.7)</td><td align="center" colspan="1" rowspan="1">169</td><td colspan="1" rowspan="1">16.6 (11.6&#8211;22.7)</td></tr><tr><td colspan="1" rowspan="1">Heart failure</td><td colspan="1" rowspan="1">72 (7.7)</td><td colspan="1" rowspan="1">10 (6.7)</td><td align="center" colspan="1" rowspan="1">82</td><td colspan="1" rowspan="1">12.2 (6.4&#8211;20.6)</td></tr><tr><td colspan="1" rowspan="1">Other</td><td colspan="1" rowspan="1">150 (16.0)</td><td colspan="1" rowspan="1">23 (15.3)</td><td align="center" colspan="1" rowspan="1">173</td><td colspan="1" rowspan="1">13.3 (8.9&#8211;18.9)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="5" colspan="1">Length of UOHI stay in days</td><td colspan="1" rowspan="1">&#8804; 5</td><td colspan="1" rowspan="1">289 (30.8)</td><td colspan="1" rowspan="1">46 (30.7)</td><td align="center" colspan="1" rowspan="1">335</td><td colspan="1" rowspan="1">13.7 (10.4&#8211;17.7)</td></tr><tr><td colspan="1" rowspan="1">6&#8211;8</td><td colspan="1" rowspan="1">237 (25.2)</td><td colspan="1" rowspan="1">38 (25.3)</td><td align="center" colspan="1" rowspan="1">275</td><td colspan="1" rowspan="1">13.8 (10.1&#8211;18.3)</td></tr><tr><td colspan="1" rowspan="1">9&#8211;13</td><td colspan="1" rowspan="1">185 (19.7)</td><td colspan="1" rowspan="1">33 (22.0)</td><td align="center" colspan="1" rowspan="1">218</td><td colspan="1" rowspan="1">15.1 (10.9&#8211;20.3)</td></tr><tr><td colspan="1" rowspan="1">&#8805; 14</td><td colspan="1" rowspan="1">228 (24.3)</td><td colspan="1" rowspan="1">33 (22.0)</td><td align="center" colspan="1" rowspan="1">261</td><td colspan="1" rowspan="1">12.6 (9.0&#8211;17.1)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="3" colspan="1">Readmitted to UOHI within 30 days</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">894 (95.2)</td><td colspan="1" rowspan="1">139 (92.7)</td><td align="center" colspan="1" rowspan="1">1033</td><td colspan="1" rowspan="1">13.5 (11.5&#8211;15.6)</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">45 (4.8)</td><td colspan="1" rowspan="1">11 (7.3)</td><td align="center" colspan="1" rowspan="1">56</td><td colspan="1" rowspan="1">19.6 (10.9&#8211;31.4)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="6" rowspan="1">Substance use and mental health</td></tr><tr><td rowspan="3" colspan="1">Tobacco use, in previous 6 months</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">831 (89.0)</td><td colspan="1" rowspan="1">102 (68.5)</td><td align="center" colspan="1" rowspan="1">933</td><td colspan="1" rowspan="1">10.9 (9.1&#8211;13.1)</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">103 (11.0)</td><td colspan="1" rowspan="1">47 (31.5)<xref rid="tbl1fnlowast" ref-type="table-fn">&#8727;</xref></td><td align="center" colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">31.3 (24.3&#8211;39.1)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="3" colspan="1">Ever used e-cigarettes</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">857 (92.0)</td><td colspan="1" rowspan="1">113 (75.8)</td><td align="center" colspan="1" rowspan="1">970</td><td colspan="1" rowspan="1">11.6 (9.7&#8211;13.8)</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">75 (8.0)</td><td colspan="1" rowspan="1">36 (24.2)<xref rid="tbl1fnlowast" ref-type="table-fn">&#8727;</xref></td><td align="center" colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">32.4 (24.3&#8211;41.5)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="3" colspan="1">Current alcohol use</td><td colspan="1" rowspan="1">Within guidelines</td><td colspan="1" rowspan="1">882 (95.1)</td><td colspan="1" rowspan="1">134 (91.2)</td><td align="center" colspan="1" rowspan="1">1016</td><td colspan="1" rowspan="1">13.2 (11.2&#8211;15.4)</td></tr><tr><td colspan="1" rowspan="1">Above guidelines</td><td colspan="1" rowspan="1">45 (4.9)</td><td colspan="1" rowspan="1">13 (8.8)<xref rid="tbl1fndagger" ref-type="table-fn">&#8224;</xref></td><td align="center" colspan="1" rowspan="1">58</td><td colspan="1" rowspan="1">22.4 (13.2&#8211;34.3)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="3" colspan="1">Opioid use, in previous 6 months</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">791 (90.0)</td><td colspan="1" rowspan="1">119 (82.6)</td><td align="center" colspan="1" rowspan="1">910</td><td colspan="1" rowspan="1">13.1 (11.0&#8211;15.4)</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">88 (10.0)</td><td colspan="1" rowspan="1">25 (17.4)<xref rid="tbl1fndagger" ref-type="table-fn">&#8224;</xref></td><td align="center" colspan="1" rowspan="1">113</td><td colspan="1" rowspan="1">22.1 (15.2&#8211;30.4)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">6</td><td align="center" colspan="1" rowspan="1">66</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="3" colspan="1">History of mental health diagnosis</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">724 (79.6)</td><td colspan="1" rowspan="1">91 (61.9)</td><td align="center" colspan="1" rowspan="1">815</td><td colspan="1" rowspan="1">11.2 (9.1&#8211;13.5)</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">186 (20.4)</td><td colspan="1" rowspan="1">56 (38.1)<xref rid="tbl1fnlowast" ref-type="table-fn">&#8727;</xref></td><td align="center" colspan="1" rowspan="1">242</td><td colspan="1" rowspan="1">23.1 (18.2&#8211;28.8)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="3" colspan="1">History of depression diagnosis</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">795 (87.4)</td><td colspan="1" rowspan="1">106 (72.1)</td><td align="center" colspan="1" rowspan="1">901</td><td colspan="1" rowspan="1">11.8 (9.8&#8211;14.0)</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">115 (12.6)</td><td colspan="1" rowspan="1">41 (27.9)<xref rid="tbl1fnlowast" ref-type="table-fn">&#8727;</xref></td><td align="center" colspan="1" rowspan="1">156</td><td colspan="1" rowspan="1">26.3 (19.9&#8211;33.6)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="3" colspan="1">History of anxiety diagnosis</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">812 (89.2)</td><td colspan="1" rowspan="1">109 (74.1)</td><td align="center" colspan="1" rowspan="1">921</td><td colspan="1" rowspan="1">11.8 (9.9&#8211;14.0)</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">98 (10.8)</td><td colspan="1" rowspan="1">38 (25.9)<xref rid="tbl1fnlowast" ref-type="table-fn">&#8727;</xref></td><td align="center" colspan="1" rowspan="1">136</td><td colspan="1" rowspan="1">27.9 (20.9&#8211;35.9)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="6" rowspan="1">Social/environmental</td></tr><tr><td rowspan="3" colspan="1">Someone smokes cannabis in the home</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">907 (97.8)</td><td colspan="1" rowspan="1">132 (89.8)</td><td align="center" colspan="1" rowspan="1">1039</td><td colspan="1" rowspan="1">12.7 (10.8&#8211;14.8)</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">20 (2.2)</td><td colspan="1" rowspan="1">15 (10.2)<xref rid="tbl1fnlowast" ref-type="table-fn">&#8727;</xref></td><td align="center" colspan="1" rowspan="1">35</td><td colspan="1" rowspan="1">42.9 (27.6&#8211;59.3)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="3" colspan="1">Someone in primary social group smokes cannabis</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">826 (89.1)</td><td colspan="1" rowspan="1">82 (55.8)</td><td align="center" colspan="1" rowspan="1">908</td><td colspan="1" rowspan="1">9.0 (7.3&#8211;11.0)</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">101 (10.9)</td><td colspan="1" rowspan="1">65 (44.2)<xref rid="tbl1fnlowast" ref-type="table-fn">&#8727;</xref></td><td align="center" colspan="1" rowspan="1">166</td><td colspan="1" rowspan="1">39.2 (32.0&#8211;46.7)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>CI, confidence interval; UOHI, University of Ottawa Heart Institute.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl1fnlowast"><label>&#8727;</label><p id="ntpara0020">&#967;<sup>2</sup><italic toggle="yes">P</italic> &lt; 0.001.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl1fndagger"><label>&#8224;</label><p id="ntpara0025">&#967;<sup>2</sup><italic toggle="yes">P</italic> &lt; 0.05.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec2.2"><title>Factors associated with cannabis consumption</title><p id="p0095"><xref rid="tbl2" ref-type="table">Table&#160;2</xref> summarizes the observed associations between cannabis use and other variables. In the univariable logistic-regression models, factors associated with cannabis use in the previous 12 months were as follows: age &lt; 65 years; being unemployed or receiving disability benefits; having used tobacco in the previous 6 months; having used opioids in the previous 6 months; having someone in the home who smokes cannabis; having someone in one&#8217;s primary social group who smokes cannabis; and history of a mental health diagnosis. Two adjusted models were created, and model #1 fit the data best. In the multivariable model #1, factors independently associated with cannabis use in the previous 12 months were the following: age &lt; 64 years (age &lt; 44 years OR&#160;= 3.96 [95% CI:1.65-9.53]; age 45-64 years OR&#160;= 2.72 [95% CI:1.65-4.47]); tobacco use in the previous 6 months (OR&#160;=&#160;1.91 [95% CI: 1.18-3.07]); having someone in one&#8217;s primary social group who smokes cannabis (OR&#160;= 4.17 [95% CI:2.73-6.38]); and history of a mental health diagnosis (OR&#160;= 1.82 [95% CI: 1.19-2.79]).<table-wrap position="float" id="tbl2" orientation="portrait"><label>Table&#160;2</label><caption><p>Associations between participant characteristics and cannabis use</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" colspan="1">Variables</th><th colspan="3" rowspan="1">Cannabis use in the past 12 months, odds ratio (95% confidence interval)<hr/></th></tr><tr><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1">Model 1<hr/></th><th colspan="1" rowspan="1">Model 2<hr/></th></tr><tr><th colspan="1" rowspan="1">Univariable</th><th colspan="1" rowspan="1">Multivariable</th><th colspan="1" rowspan="1">Multivariable</th></tr></thead><tbody><tr><td colspan="4" rowspan="1">Sex</td></tr><tr><td colspan="1" rowspan="1">Male</td><td colspan="1" rowspan="1">1.20 (0.81&#8211;1.77)</td><td colspan="1" rowspan="1">1.25 (0.80&#8211;1.94)</td><td colspan="1" rowspan="1">1.26 (0.81&#8211;1.96)</td></tr><tr><td colspan="1" rowspan="1">Female</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td></tr><tr><td colspan="4" rowspan="1">Age, y</td></tr><tr><td colspan="1" rowspan="1">&#8804; 44</td><td colspan="1" rowspan="1"><bold>7.24 (3.76&#8211;13.94)</bold><xref rid="tbl2fnlowast" ref-type="table-fn">&#8727;</xref></td><td colspan="1" rowspan="1"><bold>3.96 (1.65&#8211;9.53)</bold><xref rid="tbl2fndagger" ref-type="table-fn">&#8224;</xref></td><td colspan="1" rowspan="1"><bold>3.91 (1.63&#8211;9.36)</bold><xref rid="tbl2fndagger" ref-type="table-fn">&#8224;</xref></td></tr><tr><td colspan="1" rowspan="1">45&#8211;64</td><td colspan="1" rowspan="1"><bold>3.14 (2.14&#8211;4.63)</bold><xref rid="tbl2fnlowast" ref-type="table-fn">&#8727;</xref></td><td colspan="1" rowspan="1"><bold>2.72 (1.65&#8211;4.47)</bold><xref rid="tbl2fnlowast" ref-type="table-fn">&#8727;</xref></td><td colspan="1" rowspan="1"><bold>2.74 (1.68&#8211;4.49)</bold><xref rid="tbl2fnlowast" ref-type="table-fn">&#8727;</xref></td></tr><tr><td colspan="1" rowspan="1">&#8805; 65</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td></tr><tr><td colspan="4" rowspan="1">Some postsecondary education</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">0.93 (0.65&#8211;1.33)</td><td colspan="1" rowspan="1">0.95 (0.63&#8211;1.43)</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="4" rowspan="1">Employment status</td></tr><tr><td colspan="1" rowspan="1">Employed</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td></tr><tr><td colspan="1" rowspan="1">Retired</td><td colspan="1" rowspan="1"><bold>0.64 (0.43&#8211;0.95)</bold><xref rid="tbl2fndagger" ref-type="table-fn">&#8224;</xref></td><td colspan="1" rowspan="1">1.60 (0.95&#8211;2.69)</td><td colspan="1" rowspan="1">1.60 (0.95&#8211;2.68)</td></tr><tr><td colspan="1" rowspan="1">Unemployed or receiving disability income support</td><td colspan="1" rowspan="1"><bold>1.75 (1.06&#8211;2.91)</bold><xref rid="tbl2fndagger" ref-type="table-fn">&#8224;</xref></td><td colspan="1" rowspan="1">1.33 (0.73&#8211;2.40)</td><td colspan="1" rowspan="1">1.28 (0.71&#8211;2.30)</td></tr><tr><td colspan="4" rowspan="1">Tobacco use previous 6 months</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1"><bold>3.64 (2.43&#8211;5.46)</bold><xref rid="tbl2fnlowast" ref-type="table-fn">&#8727;</xref></td><td colspan="1" rowspan="1"><bold>1.91 (1.18&#8211;3.07)</bold><xref rid="tbl2fndagger" ref-type="table-fn">&#8224;</xref></td><td colspan="1" rowspan="1"><bold>1.93 (1.20&#8211;3.09)</bold><xref rid="tbl2fndagger" ref-type="table-fn">&#8224;</xref></td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td></tr><tr><td colspan="4" rowspan="1">Current alcohol use</td></tr><tr><td colspan="1" rowspan="1">Above guidelines</td><td colspan="1" rowspan="1">1.88 (0.99&#8211;3.58)</td><td colspan="1" rowspan="1">1.82 (0.88&#8211;3.78)</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="1" rowspan="1">Within guidelines</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="4" rowspan="1">Opioid use past 6 months</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1"><bold>1.89 (1.16&#8211;3.07)</bold><xref rid="tbl2fndagger" ref-type="table-fn">&#8224;</xref></td><td colspan="1" rowspan="1">1.28 (0.73&#8211;2.23)</td><td colspan="1" rowspan="1">1.28 (0.74&#8211;2.23)</td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td></tr><tr><td colspan="4" rowspan="1">Someone smokes cannabis in the home</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1"><bold>5.08 (2.54&#8211;10.16)</bold><xref rid="tbl2fnlowast" ref-type="table-fn">&#8727;</xref></td><td colspan="1" rowspan="1">2.31 (0.99&#8211;5.42)</td><td colspan="1" rowspan="1">2.26 (0.98&#8211;5.20)</td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td></tr><tr><td colspan="4" rowspan="1">Someone in primary social group smokes cannabis</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1"><bold>6.43 (4.37&#8211;9.45)</bold><xref rid="tbl2fnlowast" ref-type="table-fn">&#8727;</xref></td><td colspan="1" rowspan="1"><bold>4.17 (2.73&#8211;6.38)</bold><xref rid="tbl2fnlowast" ref-type="table-fn">&#8727;</xref></td><td colspan="1" rowspan="1"><bold>4.22 (2.76&#8211;6.44)</bold><xref rid="tbl2fnlowast" ref-type="table-fn">&#8727;</xref></td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td></tr><tr><td colspan="4" rowspan="1">History of mental health diagnosis</td></tr><tr><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1"><bold>2.42 (1.67&#8211;3.49)</bold><xref rid="tbl2fnlowast" ref-type="table-fn">&#8727;</xref></td><td colspan="1" rowspan="1"><bold>1.82 (1.19&#8211;2.79)</bold><xref rid="tbl2fndagger" ref-type="table-fn">&#8224;</xref></td><td colspan="1" rowspan="1"><bold>1.82 (1.19&#8211;2.78)</bold><xref rid="tbl2fndagger" ref-type="table-fn">&#8224;</xref></td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td><td colspan="1" rowspan="1">1.0 (Ref)</td></tr></tbody></table><table-wrap-foot><fn id="tspara0005"><p>Bold font indicates statistical significance.</p></fn><fn id="tspara0025"><p>NA, not applicable; Ref, reference category.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fnlowast"><label>&#8727;</label><p id="ntpara0030"><italic toggle="yes">P</italic> &lt; 0.001.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fndagger"><label>&#8224;</label><p id="ntpara0035"><italic toggle="yes">P</italic> &lt; 0.05.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec2.3"><title>Perceptions of cannabis use</title><p id="p0100">Compared to non-users, those who had used cannabis in the past 12 months were more likely to perceive cannabis as being safe to use, including for those with heart disease (Mann-Whitney <italic toggle="yes">U</italic>&#160;= 52252.50; n<sub>1</sub>&#160;= 936; n<sub>2</sub>&#160;= 148; <italic toggle="yes">P</italic>&#160;&lt;&#160;0.001, two-tailed). Cannabis users were also more likely to support the legalization of cannabis (Mann-Whitney <italic toggle="yes">U</italic>&#160;=&#160;36398.50; n<sub>1</sub>&#160;= 933; n<sub>2</sub>&#160;= 150; <italic toggle="yes">P</italic> &lt; 0.001, two-tailed) and to report that they intended to increase their cannabis use now that it had been legalized (<italic toggle="yes">X</italic><sup><italic toggle="yes">2</italic></sup>&#160;= 35.22; <italic toggle="yes">P</italic> &lt; 0.001).</p></sec><sec id="sec2.4"><title>Patterns of cannabis use</title><p id="p0105"><xref rid="tbl3" ref-type="table">Table&#160;3</xref> presents the characteristics of cannabis users. Among all cannabis users, nearly half reported using cannabis daily. Over two-thirds reported smoking cannabis, and nearly half reported using edibles. Smoking and vaping were the primary means of cannabis delivery. Although half reported using cannabis principally for recreational purposes, almost 30% reported using it for medical reasons without a prescription, and 9.0% reported having a prescription. For pain relief, to relax or to relieve stress and anxiety, and to aid sleep were the most reported reasons for cannabis use. Over 44% (n&#160;= 63) reported a history of tobacco and cannabis co-use (ever use and past 6-month use).<table-wrap position="float" id="tbl3" orientation="portrait"><label>Table&#160;3</label><caption><p>Patterns of use among participants who had used cannabis in the past 12 months (n = 150)</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="1">Variable</th><th colspan="1" rowspan="1">n (%), unless otherwise stated</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">Sex</td><td colspan="1" rowspan="1">Male</td><td colspan="1" rowspan="1">110 (73.3)</td></tr><tr><td colspan="1" rowspan="1">Female</td><td colspan="1" rowspan="1">40 (26.7)</td></tr><tr><td rowspan="3" colspan="1">Age group, y</td><td colspan="1" rowspan="1">&#8804; 44</td><td colspan="1" rowspan="1">18 (12.0)</td></tr><tr><td colspan="1" rowspan="1">45&#8211;64</td><td colspan="1" rowspan="1">86 (57.3)</td></tr><tr><td colspan="1" rowspan="1">&#8805; 65</td><td colspan="1" rowspan="1">46 (30.7)</td></tr><tr><td rowspan="2" colspan="1">Age first tried cannabis, y, mean (SD)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">31.0 (57.1)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">7</td></tr><tr><td rowspan="4" colspan="1">Primary form of cannabis used</td><td colspan="1" rowspan="1">Smoking or vaping</td><td colspan="1" rowspan="1">84 (59.6)</td></tr><tr><td colspan="1" rowspan="1">Edibles</td><td colspan="1" rowspan="1">41 (29.1)</td></tr><tr><td colspan="1" rowspan="1">Concentrates or topicals or pills or other</td><td colspan="1" rowspan="1">16 (11.3)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">9</td></tr><tr><td rowspan="3" colspan="1">Smoked cannabis in the past 12 mo (vaping not included)</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">99 (67.8)</td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">47 (32.2)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">4</td></tr><tr><td rowspan="3" colspan="1">Consumed edible cannabis in the past 12 mo</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">65 (44.5)</td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">81 (55.5)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">4</td></tr><tr><td rowspan="6" colspan="1">Frequency of cannabis use</td><td colspan="1" rowspan="1">Everyday</td><td colspan="1" rowspan="1">68 (47.2)</td></tr><tr><td colspan="1" rowspan="1">Every 2&#8211;3 days</td><td colspan="1" rowspan="1">10 (6.9)</td></tr><tr><td colspan="1" rowspan="1">Once a week</td><td colspan="1" rowspan="1">16 (11.1)</td></tr><tr><td colspan="1" rowspan="1">Once or twice a month</td><td colspan="1" rowspan="1">15 (10.4)</td></tr><tr><td colspan="1" rowspan="1">Less than once a month</td><td colspan="1" rowspan="1">35 (24.3)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">6</td></tr><tr><td rowspan="5" colspan="1">Main reason for cannabis use</td><td colspan="1" rowspan="1">Nonmedical use (recreational)</td><td colspan="1" rowspan="1">67 (46.5)</td></tr><tr><td colspan="1" rowspan="1">Medical use without a prescription</td><td colspan="1" rowspan="1">41 (28.5)</td></tr><tr><td colspan="1" rowspan="1">Both medical and nonmedical use</td><td colspan="1" rowspan="1">23 (16.0)</td></tr><tr><td colspan="1" rowspan="1">Medical use with a prescription</td><td colspan="1" rowspan="1">13 (9.0)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">6</td></tr><tr><td rowspan="5" colspan="1">Specific reasons for using cannabis</td><td colspan="1" rowspan="1">For enjoyment/fun or social reasons</td><td colspan="1" rowspan="1">76 (53.9)</td></tr><tr><td colspan="1" rowspan="1">To alleviate pain</td><td colspan="1" rowspan="1">48 (34.0)</td></tr><tr><td colspan="1" rowspan="1">For relaxation or to manage anxiety or to relieve stress</td><td colspan="1" rowspan="1">48 (34.0)</td></tr><tr><td colspan="1" rowspan="1">To help sleep</td><td colspan="1" rowspan="1">37 (26.2)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">9</td></tr><tr><td rowspan="3" colspan="1">Driven a motor vehicle within 2 h of using cannabis, in past 12 mo</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">20 (14.0)</td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">123 (86.0)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">7</td></tr><tr><td rowspan="3" colspan="1">Ever used cannabis and tobacco together</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">45 (31.5)</td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">98 (68.5)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">7</td></tr><tr><td rowspan="3" colspan="1">Tobacco use previous 6 mo</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">47 (31.5)</td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">102 (68.5)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">1</td></tr><tr><td rowspan="3" colspan="1">Has a healthcare provider ever asked about your cannabis use?</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">68 (49.6)</td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">69 (50.4)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">13</td></tr><tr><td rowspan="4" colspan="1">Should a healthcare provider ask about your cannabis use?</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">102 (70.8)</td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">24 (16.7)</td></tr><tr><td colspan="1" rowspan="1">I don't know</td><td colspan="1" rowspan="1">18 (12.5)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">6</td></tr><tr><td rowspan="4" colspan="1">Intention to quit or reduce cannabis in the next 6 mo</td><td colspan="1" rowspan="1">Yes, planning to quit or reduce</td><td colspan="1" rowspan="1">21 (14.7)</td></tr><tr><td colspan="1" rowspan="1">Recently quit</td><td colspan="1" rowspan="1">34 (23.8)</td></tr><tr><td colspan="1" rowspan="1">No plans to quit or reduce</td><td colspan="1" rowspan="1">88 (61.5)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">7</td></tr><tr><td rowspan="3" colspan="1">Increased personal cannabis use since legalized in Canada</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">39 (27.5)</td></tr><tr><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">103 (72.5)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">8</td></tr><tr><td rowspan="3" colspan="1">Knowledge of THC content in one&#8217;s cannabis</td><td colspan="1" rowspan="1">Knows dose</td><td colspan="1" rowspan="1">40 (28.4)</td></tr><tr><td colspan="1" rowspan="1">Does NOT know dose</td><td colspan="1" rowspan="1">101 (71.6)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">9</td></tr><tr><td rowspan="3" colspan="1">Knowledge of CBD content in one&#8217;s cannabis</td><td colspan="1" rowspan="1">Knows dose</td><td colspan="1" rowspan="1">24 (16.7)</td></tr><tr><td colspan="1" rowspan="1">Does NOT know dose</td><td colspan="1" rowspan="1">120 (83.3)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">6</td></tr><tr><td rowspan="4" colspan="1">Knowledge of cannabis dose in one&#8217;s edibles</td><td colspan="1" rowspan="1">Knows dose</td><td colspan="1" rowspan="1">23 (33.3)</td></tr><tr><td colspan="1" rowspan="1">Does NOT know dose</td><td colspan="1" rowspan="1">46 (66.7)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">12</td></tr><tr><td colspan="1" rowspan="1">Does not use edibles</td><td colspan="1" rowspan="1">69</td></tr><tr><td rowspan="3" colspan="1">Knowledge of strain(s) of cannabis used</td><td colspan="1" rowspan="1">Knows strain used</td><td colspan="1" rowspan="1">61 (44.2)</td></tr><tr><td colspan="1" rowspan="1">Does NOT know strain used</td><td colspan="1" rowspan="1">77 (55.8)</td></tr><tr><td colspan="1" rowspan="1">Missing</td><td colspan="1" rowspan="1">12</td></tr><tr><td colspan="1" rowspan="1">Number of reported higher-risk cannabis-use behaviours per LRCUG, mean (SD)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">2.3 (1.2)</td></tr></tbody></table><table-wrap-foot><fn><p>CBD, cannabidiol; LRCUG, lower-risk cannabis-use guidelines; SD, standard deviation; THC, tetrahydrocannabinol.</p></fn></table-wrap-foot></table-wrap></p><p id="p0110">Over one-quarter of cannabis users (n&#160;= 39) reported that they had increased their consumption since cannabis became legalized. Nearly all cannabis users (96.7%) reported at least one higher-risk behaviour as per the LRCUGs.</p><p id="p0115">Over 71% (n&#160;= 101) of patients did not know the dose of THC in their cannibis, and 83.3% did not know the dose of CBD, and &gt; 55% did not know what strain(s) of cannabis they used (Indica, Sativa, Hybridized) or whether it was synthetic.</p><p id="p0120">Most cannabis users (61.5%) indicated that they did not want to quit or reduce cannabis use in the next 6 months. When intentions to quit were stratified by patients&#8217; main reason for using cannabis, 76.9% of patients (10 of 13) who use cannabis for medical reasons with a prescription had no intentions to quit in the next 6 months, vs 60.0% of recreational users (26 of 65), 60.0% of those using cannabis for medical reasons without a prescription (24 of 40), and 60.9% of those using cannabis for both recreational and medical purposes (14 of 23).</p></sec></sec><sec id="sec3"><title>Discussion</title><p id="p0125">To our knowledge, this evaluation provides the first description of patterns of cannabis use among Canadian cardiac inpatients. The prevalence of cannabis use in the previous 12 months among our sample was approximately 14%, with nearly half using cannabis daily. Cardiac patients who used cannabis were most likely to smoke or vape their cannabis and were, on average, 9 years younger than patients who did not use cannabis. Compared to Canada&#8217;s LRCUGs, 96.7% of cannabis users reported &#8805; 1 higher-risk use behaviour (mean&#160;= 2.3, standard deviation&#160;= 1.2). Over 60% of cannabis users expressed no intention to quit or reduce cannabis use in the next 6 months. The majority (70.8%) felt that healthcare providers should be discussing cannabis use with patients, despite only half of patients reporting ever being asked if they use cannabis.</p><p id="p0130">Cannabis use rates in cardiac patients may be up to 10% higher than rates reported by Canadians of the same age group in the general population.<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> In the third quarter of 2019, the Canadian National Cannabis Survey found that 24.8% (95% CI 22.7%-27.1%) of Canadians aged 25-44 years, and 10.3% (95% CI 9.1%-11.5%) of Canadians aged 45-64 years were current cannabis users (past-3-month use), compared to 36.7% (95% CI 24.3%-50.7%) and 20.3% (95% CI 16.7%-24.3%) in our corresponding age groups, respectively.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> Given the small sample size, different period prevalence (3&#160;vs 12 months), and the larger confidence intervals in our cardiac sample, no definitive conclusions can be drawn.</p><p id="p0135">Factors independently associated with cannabis use in our sample were as follows: being younger than 65 years; having used tobacco in the previous 6 months; having someone in one&#8217;s primary social group that smokes cannabis; and having a history of a mental health diagnosis. These findings are consistent with the CCS, which has repeatedly found that Canadians who use cannabis tend to be younger.<xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib28" ref-type="bibr">28</xref>, <xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib30" ref-type="bibr">30</xref>, <xref rid="bib31" ref-type="bibr">31</xref> Many studies also have found an association between tobacco use and cannabis use.<xref rid="bib32" ref-type="bibr">32</xref>, <xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib34" ref-type="bibr">34</xref> The influence of social environments was observed in the 2020 Canadian National Cannabis Survey, which found that 72% of Canadians who reported using cannabis in the past 12 months had someone in their household who also used cannabis, compared to only 10% of Canadians who had not used cannabis.<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> The association between cannabis use and certain mental health diagnoses has been well-documented; a recent Canadian study found that over half of those who used cannabis reported doing so to manage symptoms of mental health issues, particularly those with bipolar disorder (90.8%) and posttraumatic stress disorder (90.7%).<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref></p><p id="p0140">When the cannabis use characteristics reported among our cardiac inpatient sample were compared to Canada&#8217;s LRCUGs,<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> nearly all patients had at least one higher-risk use behaviour. This finding is similar to findings of Goodman et&#160;al.,<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> who examined adherence to LRCUGs in the general population and found that 88.8% of cannabis users reported one or more higher-risk use behaviours. In our sample, over 54% of users consumed cannabis more than once per week, and nearly half were daily users. Any use level above once per week is considered high-risk use, per the LRCUGs.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> In comparison, according to the 2019 and the 2020 CCS, only 18% of Canadian cannabis users in the general population reported using cannabis daily.<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> The most hazardous method of consumption is to smoke cannabis,<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> the primary form of consumption in over two-thirds of our sample. We also noted that certain misperceptions and knowledge gaps regarding cannabis were present in our patient population and may pose additional risks and challenges. The safety of cannabis use, including for those with heart disease, was perceived as significantly greater by patients who had used cannabis in the previous 12 months compared to non-users. This finding is in contrast with the mounting evidence of the cardiac risks associated with cannabis use.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="bib2" ref-type="bibr"><sup>2</sup></xref><sup>,</sup><xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> Users demonstrated little knowledge of the dose or proportion of THC and CBD in their cannabis products, or of the strain of cannabis being consumed. Overall, our survey findings suggest that cardiac inpatients are engaging in a variety of higher-risk cannabis-use behaviours, which suggest a potential need for patient education around lower-risk use of cannabis. The 2020 Scientific Statement from the American Heart Association<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> also supports these conclusions and recommends increased education about cannabis for patients and clinicians.</p><p id="p0145">It is unclear what would constitute safe or lower-risk cannabis use for an individual with CVD. A 2022 update to the LRCUGs<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> has added a recommendation (#11) specifying that those with CVD may be at risk of acute harm from cannabis use, should avoid inhaling high-potency cannabis, and potentially should avoid using cannabis altogether. The type of cannabinoid ingested, be it THC or CBD, may also affect risk for patients with cardiovascular issues. THC, especially high-potency THC, appears to have negative effects on the cardiovascular system.<xref rid="bib38" ref-type="bibr">38</xref>, <xref rid="bib39" ref-type="bibr">39</xref>, <xref rid="bib40" ref-type="bibr">40</xref> Yet very preliminary findings (case-report, observational studies, anecdotal evidence) suggest that CBD could have positive cardiovascular effects.<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> When determining what level of cannabis use is safe or lower risk for patients with CVD, one also must determine how cannabis interacts with cardiovascular drugs. Preliminary evidence suggests that cannabis may interact with a variety of cardiovascular medications.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> Overall, further research is needed to develop comprehensive guidance relating to the safe use of cannabis for cardiac patients.</p><p id="p0150">The prevalence of cigarette and cannabis co-use among our sample of cardiac inpatients, was slightly lower than the co-use prevalence among a sample of cannabis users from the general population in Ontario (31.5% vs 41.7%),<xref rid="bib41" ref-type="bibr"><sup>41</sup></xref> yet the prevalence of mixing tobacco with cannabis was nearly identical (31.1% [95% CI 24.3%-39.4%] vs 31.1% [95% CI 27.0%-35.9%]). The lower percentage of co-use in our sample may be due to the lower prevalence of tobacco use in the Ottawa area (14.6%), compared to that in the rest of Ontario (16.9%).<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> The rate of tobacco use among cannabis users was much higher than that among non-users of cannabis in our cardiac inpatient population (31.3% vs 10.9%). A recent observational cohort study of &gt; 35,000 patients seeking tobacco-cessation treatment in Ontario, Canada found that cannabis users were 15% less likely to quit tobacco smoking than were cigarette smokers who did not co-use cannabis (OR 0.85, 95% CI 0.77-0.93).<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref> Our group found similar results in a recent tobacco-cessation evaluation among hospital inpatients: cannabis use was the strongest predictor of not being able to quit tobacco smoking.<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref> A recent meta-analysis and narrative review of 20 studies (12 randomized controlled trials and 8 uncontrolled trials) showed weak evidence for the effectiveness of single- or multi-substance interventions for tobacco and/or cannabis cessation.<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref> Given that tobacco smoking remains the most important modifiable risk factor for primary and secondary prevention of cardiovascular events, more high-quality evidence is needed to determine what interventions may be most effective at helping co-users with smoking cessation. Furthermore, cannabis use may impact other CVD risk factors (ie, physical activity, alcohol use, mental health, healthy eating). More research is needed to understand the relationships between cannabis use and these modifiable risk factors.</p><p id="p0155">Over half of our patients (50.4%) reported that no healthcare provider had ever asked them about their cannabis use; 70.8% of our patients felt that healthcare providers should do so. However, over 60% indicated that they had no intention to quit or reduce cannabis use in the next 6 months. These findings suggest a window of opportunity for healthcare providers to have discussions about cannabis use and provide patients with education and support or referral to cessation services.</p><sec id="sec3.1"><title>Limitations</title><p id="p0160">A cross-sectional survey design was used, as this design is ideal for measuring prevalence, although no causal conclusions can be derived. Attempts were made to minimize interviewer bias by providing training to interviewers and developing a standardized protocol for survey administration. To reduce sampling bias, a patient census was used to contact a consecutive series of patients, and eligibility criteria were made as broad as possible. Future surveys should consider the use of interpreters to capture responses from patients who do not speak English or French. A possible limitation is that nonresponders were significantly and systematically different than responders. Nonresponse bias was minimized by attempting to reach patients when they were in the hospital and at least 5 times via telephone, postdischarge, and by clearly explaining the purpose of the evaluation survey. A high response rate of 73.0% was achieved.</p><p id="p0165">Most responses were self-reported. Studies that have examined the sensitivity and specificity of self-reported cannabis use have found that the sensitivity of self-report of cannabis use, compared to biochemical verification, ranges from 33.9% (prenatal cannabis use)<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref> to 85.7%<xref rid="bib47" ref-type="bibr"><sup>47</sup></xref> and that specificity ranges from 84%<xref rid="bib48" ref-type="bibr"><sup>48</sup></xref> to 99%.<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref> Overall, the literature supports self-report measures of cannabis use in epidemiologic studies. Patients may not have admitted to using cannabis; thus, the survey results may underestimate the prevalence and characteristics of cannabis use. However, &#8220;mis-reporting&#8221; rates likely have improved post-legalization.</p><p id="p0170">This evaluation was conducted at one highly specialized tertiary-care cardiac hospital, in Eastern Ontario, Canada, among cardiac inpatients. Due to the single-site design and small sample size, application of these results to other patient populations in other geographic locations should be done with caution.</p></sec></sec><sec id="sec4"><title>Conclusion</title><p id="p0175">Cannabis use is prevalent among cardiac patients. Cardiac inpatients who use cannabis are significantly younger than patients who do not use cannabis, and the prevalence among cardiac patients may be higher than that among age-matched people in the general population. Many patients are not following lower-risk-use guidelines, have significant knowledge gaps related to cannabis, and have a low level of intention to quit. Given the known cardiovascular effects of cannabis use, an important approach for health providers is to systematically ask patients about their cannabis use and, when possible, provide education about lower-risk use. Further work is necessary to better understand the combined effects of THC and CBD on the cardiovascular system, and to develop better guidelines, educational tools, and, potentially, interventions for cardiac patients who use cannabis.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Odom</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>R.</given-names></name><name name-style="western"><surname>Loustalot</surname><given-names>F.</given-names></name><name name-style="western"><surname>Coleman King</surname><given-names>S.</given-names></name></person-group><article-title>Nonmedical marijuana use and cardiovascular events : a systematic review</article-title><source>Public Health Rep</source><volume>137</volume><year>2022</year><fpage>62</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">33636088</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0033354920988285</pub-id><pub-id pub-id-type="pmcid">PMC8721763</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Bing</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Moulin</surname><given-names>A.K.</given-names></name><etal/></person-group><article-title>Cannabis use and acute coronary syndrome</article-title><source>Clin Toxicol</source><volume>57</volume><year>2019</year><fpage>831</fpage><lpage>841</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15563650.2019.1601735</pub-id><pub-id pub-id-type="pmid">30964363</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name name-style="western"><surname>Zongo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dyck</surname><given-names>J.R.B.</given-names></name><etal/></person-group><article-title>Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study</article-title><source>BMC Cardiovasc Disord</source><volume>21</volume><year>2021</year><fpage>426</fpage><pub-id pub-id-type="pmid">34507536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12872-021-02229-6</pub-id><pub-id pub-id-type="pmcid">PMC8431905</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Blohm</surname><given-names>E.</given-names></name><name name-style="western"><surname>Toles</surname><given-names>K.A.</given-names></name><etal/></person-group><article-title>The association of cannabis use and cardiac dysrhythmias: a systematic review</article-title><source>Clin Toxicol</source><volume>58</volume><year>2020</year><fpage>861</fpage><lpage>869</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15563650.2020.1743847</pub-id><pub-id pub-id-type="pmid">32267189</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name name-style="western"><surname>Kalla</surname><given-names>A.</given-names></name><name name-style="western"><surname>Krishnamoorthy</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Gopalakrishnan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Figueredo</surname><given-names>V.M.</given-names></name></person-group><article-title>Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample</article-title><source>J&#160;Cardiovasc Med</source><volume>19</volume><year>2018</year><fpage>480</fpage><lpage>484</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2459/JCM.0000000000000681</pub-id><pub-id pub-id-type="pmid">29879084</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name name-style="western"><surname>Gan</surname><given-names>W.Q.</given-names></name><name name-style="western"><surname>Buxton</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Scheuermeyer</surname><given-names>F.X.</given-names></name><etal/></person-group><article-title>Risk of cardiovascular diseases in relation to substance use disorders</article-title><source>Drug Alcohol Depend</source><volume>229</volume><issue>Pt A</issue><year>2021</year><object-id pub-id-type="publisher-id">109132</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2021.109132</pub-id><pub-id pub-id-type="pmid">34768052</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name name-style="western"><surname>Goyal</surname><given-names>H.</given-names></name><name name-style="western"><surname>Awad</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Ghali</surname><given-names>J.K.</given-names></name></person-group><article-title>Role of cannabis in cardiovascular disorders</article-title><source>J&#160;Thorac Dis</source><volume>9</volume><year>2017</year><fpage>2079</fpage><lpage>2092</lpage><pub-id pub-id-type="pmid">28840009</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/jtd.2017.06.104</pub-id><pub-id pub-id-type="pmcid">PMC5542986</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name name-style="western"><surname>Subramaniam</surname><given-names>V.N.</given-names></name><name name-style="western"><surname>Menezes</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>DeSchutter</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lavie</surname><given-names>C.J.</given-names></name></person-group><article-title>The cardiovascular effects of marijuana: Are the potential adverse effects worth the high?</article-title><source>Mo Med</source><volume>116</volume><year>2019</year><fpage>146</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">31040502</pub-id><pub-id pub-id-type="pmcid">PMC6461323</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name name-style="western"><surname>Manolis</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Manolis</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Manolis</surname><given-names>A.S.</given-names></name></person-group><article-title>Cannabis associated "high" cardiovascular morbidity and mortality: marijuana smoke like tobacco smoke? A d&#233;j&#224; vu/d&#233;j&#224; v&#233;cu story?</article-title><source>Mini Rev Med Chem</source><volume>19</volume><year>2019</year><fpage>870</fpage><lpage>879</lpage><pub-id pub-id-type="pmid">30426899</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1389557518666181114113947</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name name-style="western"><surname>Page</surname><given-names>R.L.</given-names><suffix>2nd</suffix></name><name name-style="western"><surname>Allen</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Kloner</surname><given-names>R.A.</given-names></name><etal/></person-group><article-title>Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American Heart Association</article-title><source>Circulation</source><volume>142</volume><year>2020</year><fpage>e131</fpage><lpage>e152</lpage><pub-id pub-id-type="pmid">32752884</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIR.0000000000000883</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name name-style="western"><surname>Betthauser</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pilz</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vollmer</surname><given-names>L.E.</given-names></name></person-group><article-title>Use and effects of cannabinoids in military veterans with posttraumatic stress disorder</article-title><source>Am J Health Syst Pharm</source><volume>72</volume><year>2015</year><fpage>1279</fpage><lpage>1284</lpage><pub-id pub-id-type="pmid">26195653</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2146/ajhp140523</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name name-style="western"><surname>Aggarwal</surname><given-names>S.K.</given-names></name></person-group><article-title>Cannabinergic pain medicine: a concise clinical primer and survey of randomized-controlled trial results</article-title><source>Clin J Pain</source><volume>29</volume><year>2013</year><fpage>162</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">22367503</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AJP.0b013e31824c5e4c</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name name-style="western"><surname>Koppel</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Brust</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Fife</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology</article-title><source>Neurology</source><volume>82</volume><year>2014</year><fpage>1556</fpage><lpage>1563</lpage><pub-id pub-id-type="pmid">24778283</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000000363</pub-id><pub-id pub-id-type="pmcid">PMC4011465</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="other" id="sref14"><article-title>Government of Canada, Taking stock of progress: Cannabis legalization and regulation in Canada</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.canada.ca/en/health-canada/programs/engaging-cannabis-legalization-regulation-canada-taking-stock-progress/document.html" id="intref0020">https://www.canada.ca/en/health-canada/programs/engaging-cannabis-legalization-regulation-canada-taking-stock-progress/document.html</ext-link></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="other" id="sref15"><person-group person-group-type="author"><collab>Government of Canada</collab></person-group><article-title>Canada's lower-risk cannabis use guidelines</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/lower-risk-cannabis-use-guidelines.html" id="intref0025">https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/lower-risk-cannabis-use-guidelines.html</ext-link></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jeffries</surname><given-names>V.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Lower risk cannabis use guidelines for Canada (LRCUG): a narrative review of evidence and recommendations</article-title><source>Can J Public Health</source><volume>102</volume><year>2011</year><fpage>324</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">22032094</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF03404169</pub-id><pub-id pub-id-type="pmcid">PMC6973752</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Richter</surname><given-names>K.P.</given-names></name></person-group><article-title>A&#160;national survey of marijuana use among US adults with medical conditions, 2016-2017</article-title><source>JAMA Netw Open</source><volume>2</volume><year>2019</year><object-id pub-id-type="publisher-id">e1911936</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2019.11936</pub-id><pub-id pub-id-type="pmcid">PMC6755533</pub-id><pub-id pub-id-type="pmid">31539078</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fadel</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Salas-Wright</surname><given-names>C.P.</given-names></name><name name-style="western"><surname>Vaughn</surname><given-names>M.G.</given-names></name></person-group><article-title>Trends of substance use among individuals with cardiovascular disease in the United States, 2015-2019</article-title><source>Int J Environ Res Public Health</source><volume>19</volume><year>2022</year><fpage>577</fpage><pub-id pub-id-type="pmid">35010837</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijerph19010577</pub-id><pub-id pub-id-type="pmcid">PMC8744837</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="other" id="sref19"><article-title>Statistics Canada, National Cannabis Survey&#8212;other versions of the questionnaire</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www23.statcan.gc.ca/imdb/p3Instr.pl?Function=getInstrumentList&amp;Item_Id=1288038&amp;UL=AV" id="intref0030">https://www23.statcan.gc.ca/imdb/p3Instr.pl?Function=getInstrumentList&amp;Item_Id=1288038&amp;UL=AV</ext-link></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="other" id="sref20"><article-title>Health Canada, The Canadian Cannabis Survey 2018&#8212;methodological report</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2018/006-18-e/report.pdf" id="intref0035">https://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2018/006-18-e/report.pdf</ext-link></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="other" id="sref21"><article-title>Health Canada, The Canadian Cannabis Survey 2019&#8212;methodological report</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2019/130-18-e/report.pdf" id="intref0040">https://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2019/130-18-e/report.pdf</ext-link></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name name-style="western"><surname>Cuttler</surname><given-names>C.</given-names></name><name name-style="western"><surname>Spradlin</surname><given-names>A.</given-names></name></person-group><article-title>Measuring cannabis consumption: psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU)</article-title><source>PloS One</source><volume>12</volume><year>2017</year><object-id pub-id-type="publisher-id">e0178194</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0178194</pub-id><pub-id pub-id-type="pmcid">PMC5446174</pub-id><pub-id pub-id-type="pmid">28552942</pub-id></element-citation></ref><ref id="bib23"><label>23</label><mixed-citation publication-type="other" id="sref47a">Statistics Canada, Canadian Tobacco, Alcohol and Drugs Survey 2017. Available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www23.statcan.gc.ca/imdb/p3Instr.pl?Function=assembleInstr&amp;lang=en&amp;Item_Id=337407" id="intref0045">https://www23.statcan.gc.ca/imdb/p3Instr.pl?Function=assembleInstr&amp;lang=en&amp;Item_Id=337407</ext-link>. Accessed 27 May 2022.</mixed-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="other" id="sref24"><person-group person-group-type="author"><collab>Statistics Canada</collab></person-group><article-title>National Cannabis Survey, third quarter 2019</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www150.statcan.gc.ca/n1/daily-quotidien/191030/dq191030a-eng.htm" id="intref0050">https://www150.statcan.gc.ca/n1/daily-quotidien/191030/dq191030a-eng.htm</ext-link></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="other" id="sref25"><person-group person-group-type="author"><collab>Canadian Centre on Substance Use and Addiction</collab></person-group><article-title>Canada's Low-Risk Alcohol Drinking Guidelines</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ccsa.ca/canadas-low-risk-alcohol-drinking-guidelines-brochure" id="intref0055">https://www.ccsa.ca/canadas-low-risk-alcohol-drinking-guidelines-brochure</ext-link></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="other" id="sref26"><person-group person-group-type="author"><collab>Statistics Canada</collab></person-group><article-title>Table&#160;1: Number and percentage of people reporting never having used, formerly using, currently using cannabis by frequency, by age group, household population aged 15 or older, Canada (provinces only), second and third quarters combined 2019</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www150.statcan.gc.ca/n1/daily-quotidien/191030/t001a-eng.htm" id="intref0060">https://www150.statcan.gc.ca/n1/daily-quotidien/191030/t001a-eng.htm</ext-link></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="other" id="sref27"><article-title>Government of Canada, Canadian Cannabis Survey 2020: summary</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html" id="intref0065">https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html</ext-link></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="other" id="sref28"><article-title>Government of Canada, Canadian Cannabis Survey 2021: summary</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2021-summary.html" id="intref0070">https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2021-summary.html</ext-link></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="other" id="sref29"><article-title>Goverment of Canada, Canadian Cannabis Survey 2018 Summary</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.canada.ca/en/services/health/publications/drugs-health-products/canadian-cannabis-survey-2018-summary.html" id="intref0075">https://www.canada.ca/en/services/health/publications/drugs-health-products/canadian-cannabis-survey-2018-summary.html</ext-link></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="other" id="sref30"><article-title>Goverment of Canada, Canadian Cannabis Survey 2017&#8212;summary</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2017-summary.html" id="intref0080">https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2017-summary.html</ext-link></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="other" id="sref31"><article-title>Government of Canada, Canadian Cannabis Survey 2019&#8212;summary</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2019-summary.html" id="intref0085">https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2019-summary.html</ext-link></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name name-style="western"><surname>Lemyre</surname><given-names>A.</given-names></name><name name-style="western"><surname>Poliakova</surname><given-names>N.</given-names></name><name name-style="western"><surname>B&#233;langer</surname><given-names>R.E.</given-names></name></person-group><article-title>The relationship between tobacco and cannabis use: a review</article-title><source>Substance Use Misuse</source><volume>54</volume><year>2019</year><fpage>130</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">30362881</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10826084.2018.1512623</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name name-style="western"><surname>Weinberger</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Delnevo</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Wyka</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Cannabis use is associated with increased risk of cigarette smoking initiation, persistence, and relapse among adults in the United States</article-title><source>Nicotine Tob Res</source><volume>22</volume><year>2020</year><fpage>1404</fpage><lpage>1408</lpage><pub-id pub-id-type="pmid">31112595</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ntr/ntz085</pub-id><pub-id pub-id-type="pmcid">PMC7364845</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name name-style="western"><surname>Agrawal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Budney</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Lynskey</surname><given-names>M.T.</given-names></name></person-group><article-title>The co-occurring use and misuse of cannabis and tobacco: a review</article-title><source>Addiction</source><volume>107</volume><year>2012</year><fpage>1221</fpage><lpage>1233</lpage><pub-id pub-id-type="pmid">22300456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1360-0443.2012.03837.x</pub-id><pub-id pub-id-type="pmcid">PMC3397803</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name name-style="western"><surname>Rup</surname><given-names>J.</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>T.P.</given-names></name><name name-style="western"><surname>Perlman</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hammond</surname><given-names>D.</given-names></name></person-group><article-title>Cannabis and mental health: prevalence of use and modes of cannabis administration by mental health status</article-title><source>Addict Behav</source><volume>121</volume><year>2021</year><object-id pub-id-type="publisher-id">106991</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.addbeh.2021.106991</pub-id><pub-id pub-id-type="pmid">34087766</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name name-style="western"><surname>Goodman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hammond</surname><given-names>D.</given-names></name></person-group><article-title>Lower-risk cannabis use guidelines: adherence in Canada and the U.S</article-title><source>Am J Prev Med</source><volume>59</volume><year>2020</year><fpage>e211</fpage><lpage>e220</lpage><pub-id pub-id-type="pmid">33158644</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amepre.2020.06.015</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name name-style="western"><surname>Archie</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Cucullo</surname><given-names>L.</given-names></name></person-group><article-title>Harmful effects of smoking cannabis: a cerebrovascular and neurological perspective</article-title><source>Front Pharmacol</source><volume>10</volume><year>2019</year><fpage>1481</fpage><pub-id pub-id-type="pmid">31920665</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2019.01481</pub-id><pub-id pub-id-type="pmcid">PMC6915047</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>B.</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bullen</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Lower-risk cannabis use guidelines (LRCUG) for reducing health harms from non-medical cannabis use: a comprehensive evidence and recommendations update</article-title><source>Int JDrug Policy</source><volume>99</volume><year>2022</year><object-id pub-id-type="publisher-id">103381</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugpo.2021.103381</pub-id><pub-id pub-id-type="pmid">34465496</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>T.-T.</given-names></name><name name-style="western"><surname>Chandy</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nishiga</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation</article-title><source>Cell</source><volume>185</volume><year>2022</year><fpage>1676</fpage><lpage>1693.e23</lpage><pub-id pub-id-type="pmid">35489334</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2022.04.005</pub-id><pub-id pub-id-type="pmcid">PMC9400797</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name name-style="western"><surname>Adamson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Di Giovanni</surname><given-names>B.</given-names></name><name name-style="western"><surname>Delgado</surname><given-names>D.H.</given-names></name></person-group><article-title>The positive and negative cardiovascular effects of cannabis</article-title><source>Expert Rev Cardiovasc Ther</source><volume>18</volume><year>2020</year><fpage>905</fpage><lpage>917</lpage><pub-id pub-id-type="pmid">33054426</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14779072.2020.1837625</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name name-style="western"><surname>Jayakumar</surname><given-names>N.</given-names></name><name name-style="western"><surname>Chaiton</surname><given-names>M.</given-names></name><name name-style="western"><surname>Goodwin</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Co-use and mixing tobacco with cannabis among Ontario adults</article-title><source>Nicotine Tob Res</source><volume>23</volume><year>2021</year><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">31867605</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ntr/ntz238</pub-id><pub-id pub-id-type="pmcid">PMC7789941</pub-id></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="other" id="sref44"><person-group person-group-type="author"><collab>Ottawa Public Health</collab></person-group><article-title>Tobacco use</article-title><comment>Available at:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ottawapublichealth.ca/en/reports-research-and-statistics/tobacco.aspx#ReferencesTobacco" id="intref0090">https://www.ottawapublichealth.ca/en/reports-research-and-statistics/tobacco.aspx#ReferencesTobacco</ext-link></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name name-style="western"><surname>Voci</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zawertailo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Baliunas</surname><given-names>D.</given-names></name><name name-style="western"><surname>Masood</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Selby</surname><given-names>P.</given-names></name></person-group><article-title>Is cannabis use associated with tobacco cessation outcome? An observational cohort study in primary care</article-title><source>Drug Alcohol Depend</source><volume>206</volume><year>2020</year><object-id pub-id-type="publisher-id">107756</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2019.107756</pub-id><pub-id pub-id-type="pmid">31786396</pub-id></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="other" id="sref46"><person-group person-group-type="author"><name name-style="western"><surname>Mullen</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Walker</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Noble</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Nicotine replacement therapy &#8216;gift cards&#8217; for hospital inpatients who smoke: a prospective before-and-after controlled pilot evaluation [e-pub ahead of print] Tob Control</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1136/tobaccocontrol-2021-056947" id="intref0100lkj">doi:10.1136/tobaccocontrol-2021-056947</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/tobaccocontrol-2021-056947</pub-id><pub-id pub-id-type="pmcid">PMC10447373</pub-id><pub-id pub-id-type="pmid">34911813</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name name-style="western"><surname>Walsh</surname><given-names>H.</given-names></name><name name-style="western"><surname>McNeill</surname><given-names>A.</given-names></name><name name-style="western"><surname>Purssell</surname><given-names>E.</given-names></name><name name-style="western"><surname>Duaso</surname><given-names>M.</given-names></name></person-group><article-title>A&#160;systematic review and Bayesian meta-analysis of interventions which target or assess co-use of tobacco and cannabis in single- or multi-substance interventions</article-title><source>Addiction</source><volume>115</volume><year>2020</year><fpage>1800</fpage><lpage>1814</lpage><pub-id pub-id-type="pmid">32003088</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/add.14993</pub-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name name-style="western"><surname>Young-Wolff</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Sarovar</surname><given-names>V.</given-names></name><name name-style="western"><surname>Tucker</surname><given-names>L.Y.</given-names></name><etal/></person-group><article-title>Validity of self-reported cannabis use among pregnant females in Northern California</article-title><source>J&#160;Addict Med</source><volume>14</volume><year>2020</year><fpage>287</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">31688149</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ADM.0000000000000581</pub-id><pub-id pub-id-type="pmcid">PMC7931632</pub-id></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name name-style="western"><surname>Mayet</surname><given-names>A.</given-names></name><name name-style="western"><surname>Esvan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Marimoutou</surname><given-names>C.</given-names></name><etal/></person-group><article-title>The accuracy of self-reported data concerning recent cannabis use in the French armed forces</article-title><source>Eur J Public Health</source><volume>23</volume><year>2013</year><fpage>328</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">23132878</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurpub/cks108</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name name-style="western"><surname>Salottolo</surname><given-names>K.</given-names></name><name name-style="western"><surname>McGuire</surname><given-names>E.</given-names></name><name name-style="western"><surname>Madayag</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Validity between self-report and biochemical testing of cannabis and drugs among patients with traumatic injury: brief report</article-title><source>J&#160;Cannabis Res</source><volume>4</volume><year>2022</year><fpage>29</fpage><pub-id pub-id-type="pmid">35676744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s42238-022-00139-8</pub-id><pub-id pub-id-type="pmcid">PMC9178863</pub-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name name-style="western"><surname>El Marroun</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tiemeier</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jaddoe</surname><given-names>V.W.</given-names></name><etal/></person-group><article-title>Agreement between maternal cannabis use during pregnancy according to self-report and urinalysis in a population-based cohort: the Generation R Study</article-title><source>Eur Addict Res</source><volume>17</volume><year>2011</year><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">20975275</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000320550</pub-id></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><title>Supplementary Material</title><p id="p0200">
<supplementary-material content-type="local-data" id="mmc1" position="float" orientation="portrait"><caption><title>Supplemental Methods S1</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc1.pdf" position="float" orientation="portrait"/></supplementary-material>
</p></sec><ack id="ack0010"><title>Acknowledgements</title><p id="p0185">The authors thank the following individuals who assisted with this evaluation: Janet Wilson, Aditi Garg, Melissa Malette, Frederick Gagnon, Arman Lira, Veronique Rowley, and Sadie Litchfield.</p><sec id="sec6"><title>Funding Sources</title><p id="p0190">The authors have no funding sources to declare.</p></sec><sec id="sec7"><title>Disclosures</title><p id="p0195">The authors have no conflicts of interest to disclose.</p></sec></ack><fn-group><fn id="d35e1548"><p id="ntpara0010"><bold>Ethics Statement:</bold> This project was reviewed by the Ottawa Health Science Network Research Ethics Board and approved as a quality-improvement evaluation.</p></fn><fn id="d35e1553"><p id="ntpara0015">See page 322 for disclosure information.</p></fn><fn id="appsec2" fn-type="supplementary-material"><p id="p0205">To access the supplementary material accompanying this article, visit <italic toggle="yes">CJC Open</italic> at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cjcopen.ca/" id="intref0010">https://www.cjcopen.ca/</ext-link> and at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cjco.2023.01.005" id="intref0015">https://doi.org/10.1016/j.cjco.2023.01.005</ext-link>.</p></fn></fn-group></back></article></pmc-articleset>